Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: July 2010

Chapter 23 - New concepts and recommendations on clinical management and research

from Section 8: - Translation to obstetrics

Summary

Comparative studies of placentation across mammals have been greatly facilitated by the availability of phylogenetic trees for the entire range of placental mammals based on molecular data. The three basic placenta types defined by Grosser on grounds of increasing invasiveness epitheliochorial, endotheliochorial, and hemochorial have routinely served as a basis for comparative discussions. Primates differ starkly from all other placental mammal orders because the two extreme kinds of placentation are represented, while the moderately invasive is not. Reliable inference of the primitive condition is an essential starting-point for successful reconstruction of the evolution of placentation in placental mammals. Having considered the general background to evolution of the placenta in primates, it is now possible to focus specifically on catarrhines Old World monkeys, apes, and humans. The architecture of the placenta is notably different in New World monkeys (platyrrhines), which diverged from catarrhines at least 40 mya.

Related content

Powered by UNSILO

References

1. VieroS, ChaddhaV, AlkazalehFet al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta 2004; 25(8–9): 735–41.
2. WhittleW, ChaddhaV, WyattPet al. Ultrasound detection of placental insufficiency in women with ‘unexplained’ abnormal maternal serum screening results. Clin Genet 2006; 69(2): 97–104.
3. BrosensI A, RobertsonW B, DixonH G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177–91.
4. BrosensI, DixonH G, RobertsonW B. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977; 84(9): 656–63.
5. PijnenborgR, AnthonyJ, DaveyD Aet al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98(7): 648–55.
6. KimY M, ChaiworapongsamT, GomezRet al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187(5): 1137–42.
7. PijnenborgR, BlandJ M, RobertsonW Bet al. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4(4): 397–413.
8. LyallF. The human placental bed revisited. Placenta 2002; 23(8–9): 555–62.
9. PijnenborgR, BlandJ M, RobertsonW Bet al. The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy. Placenta 1981; 2(4): 303–16.
10. KadyrovM, KingdomJ C, HuppertzB. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol 2006; 194(2): 557–63.
11. PalmerS K, ZamudioS, CoffinCet al. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol 1992; 80(6): 1000–6.
12. MollW. [Physiological cardiovascular adaptation in pregnancy – its significance for cardiac diseases.]Z Kardiol 2001; 90(Suppl 4): 2–9.
13. MuJ, AdamsonS L. Developmental changes in hemodynamics of uterine artery, utero- and umbilicoplacental, and vitelline circulations in mouse throughout gestation. Am J Physiol Heart Circ Physiol 2006; 291(3): H1421–8.
14. RayJ G, VermeulenM J, SchullM Jet al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366(9499): 1797–803.
15. LausmanA, KingdomJ, BradleyTet al. Subclinical atherosclerosis in association with elevated placental vascular resistance in early pregnancy. Artherosclerosis 2009. doi.org/10.1016/j.atherosclerosis.2009.02.007.
16. ToalM, KeatingS, MachinGet al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol 2008; 198(3): 330 e1–7.
17. CostaS L, ProctorL, DoddJ Met al. Screening for placental insufficiency in high-risk pregnancies: is earlier better? Placenta 2008; 29(12): 1034–40.
18. KonjeJ C, KaufmannP, BellS Cet al. A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies. Am J Obstet Gynecol 2001; 185(3): 608–13.
19. McCowanL M, RitchieK, MoL Yet al. Uterine artery flow velocity waveforms in normal and growth-retarded pregnancies. Am J Obstet Gynecol 1988; 158(3 Pt 1): 499–504.
20. CnossenJ S, MorrisR K, ter RietGet al. Use of uterine artery Doppler ultrasonography to predict preeclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008; 178(6): 701–11.
21. LiH, GudmundssonS, OlofssonP. Clinical significance of uterine artery blood flow velocity waveforms during provoked uterine contractions in high-risk pregnancy. Ultrasound Obstet Gynecol 2004; 24(4): 429–34.
22. LiH, GudmundssonS, OlofssonP. Acute increase of umbilical artery vascular flow resistance in compromised fetuses provoked by uterine contractions. Early Hum Dev 2003; 74(1): 47–56.
23. MatijevicR, JohnstonT. In vivo assessment of failed trophoblastic invasion of the spiral arteries in pre-eclampsia. Br J Obstet Gynaecol 1999; 106(1): 78–82.
24. KurjakA, KupesicS, HafnerTet al. Conflicting data on intervillous circulation in early pregnancy. J Perinat Med 1997; 25(3): 225–36.
25. SchaapsJ P, TsatsarisV. [Uteroplacental vascularization.]Gynecol Obstet Fertil 2001; 29(7–8): 509–11.
26. SchaapsJP, TsatsarisV, GoffinFet al. Shunting the intervillous space: new concepts in human uteroplacental vascularization. Am J Obstet Gynecol 2005; 192(1): 323–32.
27. HunterS, RobsonS C. Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68(6): 540–3.
28. BurtonG, WoodsA, KingdomJet al. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30: 473-82.
29. PijnenborgR, LuytenC, VercruysseLet al. Attachment and differentiation in vitro of trophoblast from normal and preeclamptic human placentas. Am J Obstet Gynecol 1996; 175(1): 30–6.
30. ZybinaT G, FrankH G, BiesterfeldSet al. Genome multiplication of extravillous trophoblast cells in human placenta in the course of differentiation and invasion into endometrium and myometrium. II. Mechanisms of polyploidization. Tsitologiia 2004; 46(7): 640–8.
31. CrossJ C. How to make a placenta: mechanisms of trophoblast cell differentiation in mice – a review. Placenta 2005; 26(Suppl A): S3–9.
32. TanakaS, KunathT, HadjantonakisA Ket al. Promotion of trophoblast stem cell proliferation by FGF4. Science 1998; 282(5396): 2072–5.
33. UyG D, DownsK M, GardnerR L. Inhibition of trophoblast stem cell potential in chorionic ectoderm coincides with occlusion of the ectoplacental cavity in the mouse. Development 2002; 129(16): 3913–24.
34. BaczykD, DunkC, HuppertzBet al. Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi. Placenta 2006; 27(4–5): 367–74.
35. GuillemotF, NagyA, AuerbachAet al. Essential role of Mash-2 in extraembryonic development. Nature 1994; 371(6495): 333–6.
36. AldersM, HodgesM, HadjantonakisA Ket al. The human Achaete-Scute homologue 2 (ASCL2, HASH2) maps to chromosome 11p15.5, close to IGF2 and is expressed in extravillus trophoblasts. Hum Mol Genet 1997; 6(6): 859–67.
37. JanatpourM J, UtsetM F, CrossJ Cet al. A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation. Dev Genet 1999; 25(2): 146–57.
38. Anson-CartwrightL, DawsonK, HolmyardDet al. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat Genet 2000; 25(3): 311–4.
39. BaczykD, SatkunaratnamA, Nait-OumesmarBet al. Complex patterns of GCM1 mRNA and protein in villous and extravillous trophoblast cells of the human placenta. Placenta 2004; 25(6): 553–9.
40. BaczykD, DrewloS, ProctorLet al. Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast. Cell Death Differ 2009; 16: 719-27.
41. YuC, ShenK, LinMet al. GCMa regulates the syncytin-mediated trophoblastic fusion. J Biol Chem 2002; 277(51): 50062–8.
42. LinC, LinM, ChenH. Biochemical characterization of the human placental transcription factor GCMa/1. Biochem Cell Biol 2005; 83(2): 188–95.
43. MalassineA, HandschuhK, TsatsarisVet al. Expression of HERV-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta. Placenta 2005; 26(7): 556–62.
44. ChenC P, ChenC Y, YangY Cet al. Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia. Placenta 2004; 25(5): 413–21.
45. DrewloS B, KingdomD J. GCM1 regulation of sflt-1 expression in first trimester placental villi: the missing link between disordered trophoblast differentiation and the development of severe early-onset preeclampsia. J Reprod Invest 2009; 16(3 Suppl): 90A.
46. SankaralingamS, ArenasI A, LaluM Met al. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 2006; 8(3): 1–20.
47. MaynardS, EpsteinF H, KarumanchiS A. Preeclampsia and angiogenic imbalance. Annu Rev Med 2008; 59: 61–78.
48. RedlineR W. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007; 38(10): 1439–46.
49. van DijkM, MuldersJ, PoutsmaAet al. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet 2005; 37(5): 514–9.
50. BerendsA L, Bertoli-AvellaA M, de GrootC Jet al. STOX1 gene in pre-eclampsia and intrauterine growth restriction. BJOG 2007; 114(9): 1163–7.
51. KivinenK, PetersonH, HiltunenLet al. Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Eur J Hum Genet 2007; 15(4): 494–7.
52. van DjikM, DunkC, OudejansC Bet al. Preeclampsia susceptibility gene STOX1 in migration and invasion of extravillous trophoblasts. Placenta 2008; 29(8): A7.
53. RigourdV, ChauvetC, ChelbiS Tet al. STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS ONE 2008; 3(12): e3905.
54. OudejansC B, van DijkM, OosterkampMet al. Genetics of preeclampsia: paradigm shifts. Hum Genet 2007; 120(5): 607–12.
55. AdamsonS L, LuY, WhiteleyK Jet al. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002; 250(2): 358–73.
56. NanaevA, ChwaliszK, FrankH Get al. Physiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extravillous trophoblast. Cell Tissue Res 1995; 282(3): 407–21.
57. LyallF. Development of the utero-placental circulation: the role of carbon monoxide and nitric oxide in trophoblast invasion and spiral artery transformation. Microsc Res Tech 2003; 60(4): 402–11.
58. BainbridgeS A, SmithG N. HO in pregnancy. Free Radic Biol Med 2005; 38(8): 979–88.
59. PatelP, VatishM, HeptinstallJet al. The endogenous production of hydrogen sulphide in intrauterine tissues. Reprod Biol Endocrinol 2009; 7: 10.
60. KanasakiK, PalmstenK, SugimotoHet al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008; 453(7198): 1117–21.
61. ReisterF, FrankH G, KingdomJ Cet al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001; 81(8): 1143–52.
62. WilliamsK P, BaldwinV. The effect of ethnicity on the development of small for gestational age infants associated with hypertension in pregnancy. Am J Perinatol 1998; 15(2): 125–8.
63. SamadiA R, MayberryR M, ReedJ W. Preeclampsia associated with chronic hypertension among African-American and White women. Ethn Dis 2001; 11(2): 192–200.
64. CaugheyA B, StotlandN E, WashingtonA Eet al. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol 2005; 106(1): 156–61.
65. DeenM E, RuurdaL G, WangJet al. Risk factors for preeclampsia in multiparous women: primipaternity versus the birth interval hypothesis. J Matern Fetal Neonatal Med 2006; 19(2): 79–84.
66. ChenX K, WenS W, BottomleyJet al. In vitro fertilization is associated with an increased risk for preeclampsia. Hypertens Pregnancy 2009; 28(1): 1–12.
67. SaitoS, SakaiM, SasakiYet al. Inadequate tolerance induction may induce pre-eclampsia. J Reprod Immunol 2007; 76(1–2): 30–9.
68. ChaouatG. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 2007; 29(2): 95–113.
69. ChaouatG. Innately moving away from the Th1/Th2 paradigm in pregnancy. Clin Exp Immunol 2003; 131(3): 393–5.
70. BonvissutoA C, LalaP K, KennedyT Get al. Induction of transforming growth factor-alpha gene expression in rat decidua is independent of the conceptus. Biol Reprod 1992; 46(4): 607–16.
71. BellS C. Secretory endometrial and decidual proteins: studies and clinical significance of a maternally derived group of pregnancy-associated serum proteins. Hum Reprod 1986; 1(3): 129–43.
72. Hochner-CelnikierD, RonM, EldorAet al. Growth characteristics of human first trimester decidual cells cultured in serum-free medium: production of prolactin, prostaglandins and fibronectin. Biol Reprod 1984; 31(4): 827–36.
73. VailheB, KappM, DietlJet al. Human first-trimester decidua vascular density: an immunohistochemical study using VE-cadherin and endoglin as endothelial cell markers. Am J Reprod Immunol 2000; 44(1): 9–15.
74. PlaisierM, RodriguesS, WillemsFet al. Different degrees of vascularization and their relationship to the expression of vascular endothelial growth factor, placental growth factor, angiopoietins, and their receptors in first-trimester decidual tissues. Fertil Steril 2007; 88(1): 176–87.
75. KlentzerisL D, BulmerJ N, WarrenAet al. Endometrial lymphoid tissue in the timed endometrial biopsy: morphometric and immunohistochemical aspects. Am J Obstet Gynecol 1992; 167(3): 667–74.
76. SalamonsenL A, LathburyL J. Endometrial leukocytes and menstruation. Hum Reprod Update 2000; 6(1): 16–27.
77. KingA, BurrowsT, VermaSet al. Human uterine lymphocytes. Hum Reprod Update 1998; 4(5): 480–5.
78. DunkC, SmithS, HazanAet al. Promotion of angiogenesis by human endometrial lymphocytes. Immunol Invest 2008; 37(5): 583–610.
79. HannaJ, Goldman-WohlD, HamaniYet al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12: 1065-74.
80. SargentI L, BorzychowskiA M, RedmanC W. NK cells and human pregnancy – an inflammatory view. Trends Immunol 2006; 27(9): 399–404.
81. RileyJ K, YokoyamaW M. NK cell tolerance and the maternal-fetal interface. Am J Reprod Immunol 2008; 59(5): 371–87.
82. TabiascoJ, RabotM, Aguerre-GirrMet al. Human decidual NK cells: unique phenotype and functional properties – a review. Placenta 2006; 27(Suppl A): S34–9.
83. WuX, JinL P, YuanM Met al. Human first-trimester trophoblast cells recruit CD56brightCD16- NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor 1. J Immunol 2005; 175(1): 61–8.
84. JonesR L, HannanN J, Kaitu’uT Jet al. Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab 2004; 89(12): 6155–67.
85. HannanN J, JonesR L, CritchleyH Oet al. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling. J Clin Endocrinol Metab 2004; 89(12): 6119–29.
86. SentmanC L, MeadowsS K, WiraC Ret al. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol 2004; 173(11): 6760–6.
87. EngertS, RiegerL, KappMet al. Profiling chemokines, cytokines and growth factors in human early pregnancy decidua by protein array. Am J Reprod Immunol 2007; 58(2): 129–37.
88. Moffett-KingA. Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2(9): 656–63.
89. KoopmanL A, KopcowH D, RybalovBet al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198(8): 1201–12.
90. JokhiP P, KingA, SharkeyA Met al. Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol 1994; 153(10): 4427–35.
91. LiX F, Charnock-JonesD S, ZhangEet al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 2001; 86(4): 1823–34.
92. LashG E, SchiesslB, KirkleyMet al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol 2006; 80(3): 572–80.
93. MilneS A, CritchleyH O, DrudyT Aet al. Perivascular interleukin-8 messenger ribonucleic acid expression in human endometrium varies across the menstrual cycle and in early pregnancy decidua. J Clin Endocrinol Metab 1999; 84(7): 2563–7.
94. Charnock-JonesD S, MacphersonA M, ArcherD Fet al. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 2000; 15(Suppl 3): 85–95.
95. MilneS A, HendersonT A, KellyR Wet al. Leukocyte populations and steroid receptor expression in human first-trimester decidua; regulation by antiprogestin and prostaglandin E analog. J Clin Endocrinol Metab 2005; 90(7): 4315–21.
96. DavidA L, TorondelB, ZacharyIet al. Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther 2008; 15(19): 1344–50.
97. AvrilT, JarousseauA C, WatierHet al. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. J Immunol 1999; 162(10): 5902–9.
98. HibyS E, WalkerJ J, O’ShaughnessyMet al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200(8): 957–65.
99. HibyS E, ReganL, LoWet al. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008; 23(4): 972–6.
100. SharkeyA M, GardnerL, HibySet al. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J Immunol 2008; 181(1): 39–46.
101. SmithS, DunkC, AplinJet al. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 2009; 174: 1959-71.
102. DunkC, JonesR, SmithS, LyeS. Trophoblast leukocyte interactions mediate decidual vascular remodeling. Placenta 2007; 28(8–9): A21.
103. SaitoS, UmekageH, SakamotoYet al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 1999; 41(5): 297–306.
104. LachapelleM H, MironP, HemmingsRet al. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion: altered profile and pregnancy outcome. J Immunol 1996; 156(10): 4027–34.
105. AplinJ D, LaceyH, HaighTet al. Growth factor-extracellular matrix synergy in the control of trophoblast invasion. Biochem Soc Trans 2000; 28(2): 199–202.
106. RaghupathyR, MakhseedM, AziziehFet al. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000; 15(3): 713–8.
107. ReisterF, FrankH G, HeylWet al. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 1999; 20(2–3): 229–33.
108. Yusuf, K, KlimanH J. The fetus, not the mother, elicits maternal immunologic rejection: lessons from discordant dizygotic twin placentas. J Perinat Med 2008; 36(4): 291–6.
109. BoogG. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol 2008; 136(1): 9–15.
110. MerblY, Zucker-ToledanoM, QuintanaF Jet al. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Invest 2007; 117(3): 712–8.
111. BenirschkeK, KaufmanP, BaergenR. Pathology of the human placenta, 5th ed. New York: Springer; 2006.
112. YuC K, KhouriO, OnwudiweNet al. Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol 2008; 31(3): 310–3.
113. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99(1): 159–67.
114. ChauhanS P, GuptaL M, HendrixN Wet al. Intrauterine growth restriction: comparison of American College of Obstetricians and Gynecologists practice bulletin with other national guidelines. Am J Obstet Gynecol 2009; 200: e401–6.
115. MadazliR, SomunkiranA, CalayZet al. Histomorphology of the placenta and the placental bed of growth restricted foetuses and correlation with the Doppler velocimetries of the uterine and umbilical arteries. Placenta 2003; 24(5): 510– 6.
116. AardemaM W, OosterhofH, TimmerAet al. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta 2001; 22(5): 405–11.
117. GuibourdencheJ, FrendoJ L, PidouxGet al. Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro. Placenta 2003; 24(5): 532–9.
118. NicolaidesK H, SpencerK, AvgidouKet al. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25(3): 221–6.
119. KaganK O, WrightD, BakerAet al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 31(6): 618–24.
120. SmithG C, StenhouseE J, CrossleyJ Aet al. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87(4): 1762–7.
121. SmithG C, CrossleyJ A, AitkenD Aet al. First-trimester placentation and the risk of antepartum stillbirth. JAMA 2004; 292(18): 2249–54.
122. ProctorL, ToilM, KeatingSet al. Placental function testing predicts adverse perinatal outcomes in women with low PAPP-A at 11–13 weeks. Am J Obstet Gynecol 2008; 199(6, Supplement 1): S125.
123. HowleyH E, WalkerM, RodgerM A. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005; 192(3): 694–708.
124. RodgerM A, PaidasM. Do thrombophilias cause placenta-mediated pregnancy complications? Semin Thromb Hemost 2007; 33(6): 597–603.
125. FanZ, LarsonP J, BognackiJet al. Tissue factor regulates plasminogen binding and activation. Blood 1998; 91(6): 1987–98.
126. ReyE, GarneauP, DavidMet al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009; 7(1): 58–64.
127. GagnonA, WilsonR D, AudibertFet al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 2008; 30(10): 918–49.
128. DugoffL, HobbinsJ C, MaloneF Det al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005; 106(2): 260–7.
129. MacaraL, KingdomJ C, KaufmannPet al. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996; 17(1): 37–48.
130. DiabA E, El-BeheryM M, EbrahiemM Aet al. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2008; 102(2): 146–51.